TABLE OF CONTENT: 1. 1.Introduction 1. Research Scope 2. Market Segmentation 3. Research Methodology 4. Definitions and Assumptions 2. 2.Executive Summary 3. 3.Market Dynamics 1. Market Drivers 2. Market Restraints 3. Market Opportunities 4. 4.Key Insights 1. Prevalence of Preeclampsia by Key Regions 2. Pricing Analysis by Key Players in Major Regions 3. Technological Advancements in Preeclampsia Diagnostics 4. New Test Type Launch by Key Players 5. Key Industry Developments – Partnerships, Mergers, and Acquisitions 5. 5.Global Preeclampsia Diagnostics Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis, Insights and Forecast – By Test Type 1. Blood Tests 2. Urine Analysis 3. Market Analysis, Insights and Forecast – By Product 1. Instruments 2. Consumables 4. Market Analysis, Insights and Forecast – By End User 1. Hospitals 2. Specialty Clinics 3. Diagnostic Centers 4. Others 5. Market Analysis, Insights and Forecast – By Region 1. North America 2. Europe 3. Asia Pacific 4. Latin America 5. Middle East & Africa 6. 6.North America Preeclampsia Diagnostics Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis – By Test Type 1. Blood Tests 2. Urine Analysis 3. Market Analysis – By Product 1. Instruments 2. Consumables 4. Market Analysis – By End User 1. Hospitals 2. Specialty Clinics 3. Diagnostic Centers 4. Others 5. Market Analysis – By Country 1. U.S. 2. Canada 7. Europe Preeclampsia Diagnostics Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis – By Test Type 1. Blood Tests 2. Urine Analysis 3. Market Analysis – By Product 1. Instruments 2. Consumables 4. Market Analysis – By End User 1. Hospitals 2. Specialty Clinics 3. Diagnostic Centers 4. Others 5. Market Analysis – By Country/Sub-region 1. U.K. 2. Germany 3. France 4. Spain 5. Italy 6. Scandinavia 7. Rest of Europe 8. 8.Asia Pacific Preeclampsia Diagnostics Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis – By Test Type 1. Blood Tests 2. Urine Analysis 3. Market Analysis – By Product 1. Instruments 2. Consumables 4. Market Analysis – By End User 1. Hospitals 2. Specialty Clinics 3. Diagnostic Centers 4. Others 5. Market Analysis – By Country/Sub-region 1. Japan 2. China 3. India 4. Australia 5. Southeast Asia 6. Rest of Asia Pacific 9. 9.Latin America Preeclampsia Diagnostics Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis – By Test Type 1. Blood Tests 2. Urine Analysis 3. Market Analysis – By Product 1. Instruments 2. Consumables 4. Market Analysis – By End User 1. Hospitals 2. Specialty Clinics 3. Diagnostic Centers 4. Others 5. Market Analysis – By Country/Sub-region 1. Brazil 2. Mexico 3. Rest of Latin America 10. 10.Middle East & Africa Preeclampsia Diagnostics Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis – By Test Type 1. Blood Tests 2. Urine Analysis 3. Market Analysis – By Product 1. Instruments 2. Consumables 4. Market Analysis – By End User 1. Hospitals 2. Specialty Clinics 3. Diagnostic Centers 4. Others 5. Market Analysis – By Country/Sub-region 1. GCC Countries 2. South Africa 3. Rest of Middle East & Africa 11. Competitive Analysis 1. Key Industry Developments 2. Global Market Share Analysis (2018) 3. Competition Dashboard 4. Comparative Analysis – Major Players 5. Company Profiles (Overview, Test Types & services, SWOT analysis, Recent developments, strategies, financials (based on availability)) 1. F. Hoffmann-La Roche Ltd 1. Overview, 2. Test Types & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 2. PerkinElmer Inc. 1. Overview, 2. Test Types & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 3. DRG INSTRUMENTS GMBH 4. Thermo Fisher Scientific Inc. 1. Overview, 2. Test Types & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 5. Diabetomics, Inc. 1. Overview, 2. Test Types & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 6. Metabolomic Diagnostics Ltd. 1. Overview, 2. Test Types & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 7. Sera Prognostics 1. Overview, 2. Test Types & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 8. Siemens Healthineers AG 1. Overview, 2. Test Types & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 9. Others 1. Overview, 2. Test Types & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 12. 12.Strategic Recommendations

F. Hoffmann-La Roche Ltd PerkinElmer Inc. DRG INSTRUMENTS GMBH Thermo Fisher Scientific Inc. Diabetomics, Inc. Metabolomic Diagnostics Ltd. Sera Prognostics Siemens Healthineers AG Bayer AG Others